Healthpeak Properties (NYSE:DOC) Price Target Raised to $21.50

Healthpeak Properties (NYSE:DOC) had its target price lifted by UBS Group from $19.00 to $21.50 in a research note released on Wednesday morning,Benzinga reports. They currently have a neutral rating on the real estate investment trust’s stock.

Several other research analysts also recently issued reports on DOC. Wall Street Zen upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. Raymond James Financial started coverage on Healthpeak Properties in a research note on Wednesday, June 17th. They set a “market perform” rating on the stock. Mizuho boosted their price target on Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, July 6th. Royal Bank Of Canada increased their price objective on Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a research report on Thursday, May 14th. Finally, Scotiabank boosted their target price on Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a research report on Wednesday, May 27th. Four research analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $20.50.

Healthpeak Properties Stock Up 0.6%

Shares of NYSE:DOC opened at $21.69 on Wednesday. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. The stock has a fifty day simple moving average of $20.10 and a two-hundred day simple moving average of $18.03. Healthpeak Properties has a 12-month low of $15.70 and a 12-month high of $22.13. The stock has a market capitalization of $14.96 billion, a price-to-earnings ratio of 67.80, a PEG ratio of 3.35 and a beta of 1.02.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02. The firm had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The company’s revenue was up 7.1% on a year-over-year basis. During the same period last year, the company earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, research analysts anticipate that Healthpeak Properties will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be issued a $0.1017 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) dividend on an annualized basis and a dividend yield of 5.6%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 381.25%.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the sale, the insider directly owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.23% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. New York Life Investment Management LLC raised its stake in Healthpeak Properties by 65.8% during the 4th quarter. New York Life Investment Management LLC now owns 156,086 shares of the real estate investment trust’s stock worth $2,510,000 after acquiring an additional 61,952 shares during the period. Northside Capital Management LLC lifted its holdings in shares of Healthpeak Properties by 47.7% in the fourth quarter. Northside Capital Management LLC now owns 472,337 shares of the real estate investment trust’s stock worth $7,595,000 after buying an additional 152,579 shares in the last quarter. Russell Investments Group Ltd. boosted its position in shares of Healthpeak Properties by 176.4% during the third quarter. Russell Investments Group Ltd. now owns 3,063,569 shares of the real estate investment trust’s stock worth $58,663,000 after acquiring an additional 1,955,273 shares during the last quarter. Oak Thistle LLC bought a new stake in Healthpeak Properties in the 4th quarter valued at $3,938,000. Finally, Baillie Gifford & Co. lifted its stake in Healthpeak Properties by 613.2% in the 4th quarter. Baillie Gifford & Co. now owns 367,256 shares of the real estate investment trust’s stock worth $5,905,000 after purchasing an additional 315,763 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.